Biogazelle

About:

Biogazelle is a specialist in genomic testing solutions.

Website: http://www.biogazelle.com/

Twitter/X: Biogazelle

Top Investors: Qbic Fund

Description:

Biogazelle offers expert laboratory services in nucleic acid quantification (gene expression, mutation, and copy number analysis, antisense oligonucleotide screening) to support its customers in their development of diagnostics and therapeutics. Customized workflows for clinically relevant samples – from liquid biopsies to fixed tissues – are available. In addition, Biogazelle’s advanced RNA biomarker development program offers an end-to-end solution from RNA biomarker panel discovery (including liquid biopsies) to the development of a PCR-based molecular diagnostic test. Biogazelle also serves as a specialty lab in the field of clinical trials and in routine diagnostic settings.

Total Funding Amount:

$2.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Zwijnaarde, Oost-Vlaanderen, Belgium

Founded Date:

2007-07-25

Contact Email:

info(AT)biogazelle.com

Founders:

Jan Hellemans

Number of Employees:

11-50

Last Funding Date:

2014-10-06

IPO Status:

Private

Industries:

© 2025 bioDAO.ai